A detailed history of Exodus Point Capital Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 62,915 shares of BIIB stock, worth $9.38 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
62,915
Previous 24,856 153.12%
Holding current value
$9.38 Million
Previous $5.76 Million 111.65%
% of portfolio
0.07%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $7.2 Million - $9.01 Million
38,059 Added 153.12%
62,915 $12.2 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $4.74 Million - $5.88 Million
24,856 New
24,856 $5.76 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $38.6 Million - $43.5 Million
152,308 Added 267.9%
209,160 $53.8 Million
Q2 2023

Aug 10, 2023

SELL
$275.25 - $318.06 $13.1 Million - $15.1 Million
-47,444 Reduced 45.49%
56,852 $16.2 Million
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $6.78 Million - $7.73 Million
26,437 Added 33.95%
104,296 $29 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $6.89 Million - $8.37 Million
27,298 Added 53.99%
77,859 $21.6 Million
Q3 2022

Nov 10, 2022

SELL
$194.69 - $268.46 $1.32 Million - $1.82 Million
-6,780 Reduced 11.82%
50,561 $13.5 Million
Q2 2022

Aug 19, 2022

BUY
$187.54 - $223.02 $4.65 Million - $5.53 Million
24,791 Added 76.16%
57,341 $11.7 Million
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $3.41 Million - $4.29 Million
17,583 Added 117.48%
32,550 $6.86 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $247,879 - $318,561
1,107 Added 7.99%
14,967 $3.59 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $4.69 Million - $6.12 Million
-16,572 Reduced 54.46%
13,860 $3.92 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $7.11 Million - $11.4 Million
27,445 Added 918.81%
30,432 $10.5 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $1.5 Million - $1.76 Million
-6,176 Reduced 67.4%
2,987 $836,000
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $1.39 Million - $2.09 Million
5,872 Added 178.43%
9,163 $2.24 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $5.39 Million - $6.23 Million
-20,365 Reduced 86.09%
3,291 $934,000
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $6.12 Million - $8.1 Million
23,656 New
23,656 $6.33 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $246,804 - $313,074
-918 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $7.9 Million - $10.9 Million
-35,919 Reduced 97.51%
918 $272,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $8.01 Million - $8.98 Million
36,837 New
36,837 $8.58 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.